* Portola pharmaceuticals announces validation of marketing
authorization application (maa) by European Medicines Agency
(ema) for indexxa (andexanet alfa), a factor xa inhibitor
antidote
The post BRIEF-Portola Pharmaceuticals announces IndexXa review update appeared first on NASDAQ.